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Recently, a new regulatory circuitry has been identi-
fied in which RNAs can crosstalk with each other by
competing for shared microRNAs. Such competing
endogenousRNAs (ceRNAs) regulate the distribution
of miRNA molecules on their targets and thereby
impose an additional level of post-transcriptional
regulation. Here we identify a muscle-specific long
noncoding RNA, linc-MD1, which governs the time
of muscle differentiation by acting as a ceRNA in
mouse and human myoblasts. Downregulation or
overexpressionof linc-MD1correlatewith retardation
or anticipation of the muscle differentiation program,
respectively. We show that linc-MD1 ‘‘sponges’’
miR-133 and miR-135 to regulate the expression of
MAML1 and MEF2C, transcription factors that acti-
vate muscle-specific gene expression. Finally, we
demonstrate that linc-MD1 exerts the same control
over differentiation timing in human myoblasts, and
that its levels are strongly reduced in Duchenne
muscle cells. We conclude that the ceRNA network
plays an important role in muscle differentiation.
INTRODUCTION
One of the greatest surprises of high throughput transcriptome
analysis of the last years has been the discovery that the
mammalian genome is pervasively transcribed into many
different complex families of RNA. In addition to a large number
of alternative transcriptional start sites, termination and splicing
patterns, a complex collection of new antisense, intronic and
intergenic transcripts was found. Moreover, almost half of the
polyadenylated species resulted to be non-protein-coding
RNAs. Although many studies have helped unveiling the function358 Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc.of many small noncoding RNAs, very little is known about the
long noncoding (lncRNA) counterpart of the transcriptome. In
spite of their very low levels of expression in specific body com-
partments and thanks to the availability of sensitive detection
techniques, specific patterns of lncRNA expression in specific
cell types, tissues and developmental conditions (Amaral and
Mattick, 2008; Qureshi et al., 2010) have been defined.
So far, a large range of functions has been attributed to
lncRNAs (Mattick, 2011; Nagano and Fraser, 2011), such as
modulation of apoptosis and invasion (Khaitan et al., 2011),
reprogramming of induced pluripotent stem cells (Loewer
et al., 2010), marker of cell fate (Ginger et al., 2006) and parental
imprinting (Sleutels et al., 2002), indicating that they may repre-
sent a major regulatory component of the eukaryotic genome.
A specific mode of action in mediating epigenetic changes
through recruitment of the Polycomb Repressive Complex
(PRC) was described for the Xist and HOTAIR transcripts
(Chaumeil et al., 2006; Rinn et al., 2007). lncRNAs were also
found to act in the nucleus as antisense transcripts or as decoy
for splicing factors leading to splicing malfunctioning (Beltran
et al., 2008; Tripathi et al., 2010). In the cytoplasm, lncRNAs
were described to transactivate STAU1-mediated mRNA decay
by duplexing with 30 UTRs via Alu elements (Gong and Maquat,
2011) or, in the case of pseudogenes, to compete for miRNA
binding, thereby modulating the derepression of miRNA targets
(Poliseno et al., 2010; Salmena et al., 2011).
These findings have prompted studies directed toward the
identification of the circuitries that are regulated by these
molecules.
Muscle differentiation is a powerful system for these investiga-
tions, because it can be both recapitulated in vitro and because
the networks of transcription factors coordinating the expres-
sion of genes involved in muscle growth, morphogenesis, and
differentiation are well known and evolutionarily conserved
(Buckingham and Vincent, 2009). Moreover, recent studies
have shown that these myogenic transcription factors not only
control protein-coding genes but also regulate the expression
of specific miRNAs (Zhao et al., 2005; Rao et al., 2006). These
miRNAs act at different levels in the modulation of muscle
differentiation and homeostasis and their expression was found
to be altered in several muscular disorders such as myocardial
infarction, DuchenneMuscular Dystrophy, and othermyopathies
(Eisenberg et al., 2007; Cacchiarelli et al., 2010).
Among miRNAs specifically expressed in muscle tissue, the
most widely studied are members of the miR-1/206 and miR-
133a/133b families, which originate from three separate chro-
mosomes (Chen et al., 2006). miR-206 differs from other
members of its family because it is exclusive of skeletal muscles
(McCarthy, 2008). Moreover, at variance with other myomiRs
mainly expressed in mature muscle fibers, miR-206 expression
is enriched in differentiating satellite cells, where it represses
the stemness factor Pax7, a crucial player in the regeneration
process, as we recently demonstrated (Cacchiarelli et al., 2010).
In this study, through a detailed analysis of the genomic region
of miR-206/133b, we discovered the existence of a muscle
specific lncRNA and defined its expression profile and function.
We demonstrated that this lncRNA is involved in the timing of
muscle differentiation and acts as a natural decoy for miRNAs,
playing a crucial role in the control of factors involved in the
myogenic program.
RESULTS
linc-MD1 Is Expressed during Myoblasts Differentiation
miRNA coding regions display different genomic organizations:
while 50% are encoded in introns or exons of protein coding
genes, the other half map in ncRNA host genes or, when no
host transcript can be identified, in intergenic regions (Figure 1A).
According to this classification, muscle specific pre-miR-206
and pre-miR-133b were annotated as overlapping with a non-
coding RNA (Williams et al., 2009). With the aim of better under-
standing the transcriptional regulation of these two miRNAs, we
carried out a detailed analysis in order to identify their transcrip-
tional start sites (TSS) and promoter elements. 50 RACE analysis,
performed in differentiating myoblasts with reverse primers
surrounding the pre-miR-206 sequence, demonstrated the exis-
tence of a proximal TSS mapping about 600 bp upstream of the
pre-miR-206 sequence (proximal, Figure 1B). This region
contains E-box sequences (CANNTG) previously shown to be
functional for MyoD association (Rao et al., 2006) and mir-206
expression (Williams et al., 2009). The same analysis was also
performed with reverse primers surrounding pre-miR-133b. A
strong TSS, mapping approximately 13 Kb upstream of pre-
miR-133b sequence, was identified (distal, Figure 1B). Analysis
of the genomic region revealed the existence of a transcript
composed of three exons and two introns; with respect to this
structure, pre-miR-206 maps in the second intron, while pre-
miR-133b in the third exon (Figure 1B and Figure S1A available
online). Even if short reading frames can be detected in the
mature transcript, neither of their AUGs shows the Kozak
consensus, nor their sequences are more or less conserved
than the surrounding regions (Figure S1B), making it very unlikely
for them to be coding. Therefore, the identified transcript was
classified as a bona fide long intergenic noncoding (linc) RNA,
hereafter termed linc-MD1. Phylogenetic analysis of linc-MD1revealed high conservation in exon 1 and 2, while homology is
limited to the pre-mir-133b sequence in exon 3 (Figure 1B). All
splice junctions are conserved as well. In silico analysis
highlighted the presence of conserved E-boxes both in the distal
(DIST) and proximal (PROX) regions (Figure 1B) as well as in the
regions surrounding the second exon where minor alternative
TSSs were mapped (data not shown).
RT-PCR analysis (Figure 1C) indicates that linc-MD1 is local-
ized in the cytoplasm and is polyadenylated. Moreover, while
absent in growth conditions (GM), linc-MD1 is activated upon
shift to differentiation (DM) of mouse myoblasts, satellite cells
and MyoD-transdifferentiated fibroblasts. The expression level
of linc-MD1 parallels that ofmiR-133b upon induction of differen-
tiation, while it is uncoupled from miR-206, which is already
present in proliferating C2 myoblasts. The two bands detected
by RT-PCR reveal the presence of a 70 nucleotide splice variant
in exon 2. Northern blot analysis of poly-A+ RNA from differenti-
ating myoblasts indicates that linc-MD1 is indeed the major
pA+ product originating from this region, even though the two
alternative splice forms are not distinguishable on this gel (Fig-
ure 1D). In situ analysis confirms that linc-MD1 is not expressed
in proliferating conditions while it is induced upon myoblast
differentiation (Figure 1F).
RT-PCR analysis of linc-MD1 inmouse tissues (Figure 1E) indi-
cates that it is highly expressed in skeletal muscles of dystrophic
mdx animals (TIB and SOL), paralleling miR-206 and miR-133b
synthesis. Notably, in wild-type animals linc-MD1 is expressed
at low levels only in the soleus, while it is absent in tibialis and
other skeletal muscles (data not shown). No linc-MD1 expres-
sion is observed in nonmuscle tissues (LIV and Figure S1C) nor
in heart (HEA), thus indicating that also linc-MD1, similarly to
miR-206, is restricted to skeletal muscles. In situ analysis
(Figure 1G) on WT and mdx muscles indicates that linc-MD1
expression occurs exclusively in newly regenerating fibers
(characterized by centronucleated fibers), abundant in dystro-
phic conditions, similarly to what previously shown for miR-206
(Cacchiarelli et al., 2010, Yuasa et al., 2008). No expression is
instead detected in mature terminally differentiated fibers, as
shown in wild-type animals devoid of regenerating fibers. The
low level of linc-MD1 found in the soleus would therefore suggest
that some degree of regeneration occurs in this district known to
have a high content of satellite cells (Charge` and Rudniki, 2004).
These data indicate that linc-MD1 is muscle-specific and is
activated upon myoblast differentiation.
Identification of Regulatory Elements Directing
linc-MD1 and miR-206/133b Expression
Promoter fusion experiments with the Distal (DIST) and Proximal
(PROX) regions were performed in order to test their role in tran-
scription. 810 and 310 nucleotides of DIST and PROX regions
respectively, were cloned upstream of either the murine pre-
miR-223 (Ballarino et al., 2009) sequence (D-miR-223 and
P-miR-223) or the firefly luciferase coding region (D-FLuc and
P-FLuc). Their promoter activity was tested in mouse C2
myoblasts in proliferation (GM, white bars) versus differentiation
(DM, black bars) conditions. Figure 2A shows that the PROX
element is already active in GM, in agreement with basal miR-
206 expression (see Figure 1C). Upon induction of differentiation,Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc. 359
Figure 1. Muscle-Specific lincRNA Profiling
(A) Human miRNA genomic location relative to their host genes.
(B) Schematic representation of the murine miR-206/133b genomic locus. Upper panel shows transcriptional start sites (TSS, indicated by arrows) mapped
through 50 RACE analysis in differentiatedmyoblasts. The genomic structure of the identified linc-MD1 and the exon-intron lengths are shown (conserved exons in
black, nonconserved 30-portions in dash) as well as pre-miRNA sequences. Lower panel shows conserved regions among vertebrates together with E-boxes and
regulatory elements (DIST, PROX and pA signals).
(C) RT-PCR for linc-MD1, pri-miR-206, and pri-miR-133b expression performed in mouse myoblasts in growth (GM) or differentiation (DM) conditions. The total,
nuclear (nuc), cytoplasmic (cyt), polyadenylated (pA+) and nonpolyadenylated (pA-) RNA fractions are shown. The same analysis was also performed in primary
satellite cells in GM and DM conditions and in mouse embryonic fibroblasts (MEFs) infected with a MyoD expressing lentivirus (MyoD) or control (gfp). HPRT
mRNA was used as endogenous control.
(D) Northern blot analysis for linc-MD1 in the poly-A+ fraction from mouse myoblasts in GM and DM conditions.
(E) RT-PCR for linc-MD1, pri-miR-206, pri-miR-133b performed on RNA from liver (LIV), heart (HEA), tibialis anterior (TIB) and soleus (SOL) of wild-type (WT) and
mdx mice.
(F) In situ analysis with a DIG-labeled linc-MD1 probe in C2 myoblasts in GM and DM. (G) In situ analysis with DIG-labeled linc-MD1 and miR-206 probes in wild-
type (WT) and mdx gastrocnemius cryosections; DAPI staining (light blue) is also shown.
Original magnification is 203. The scale bar represents 100 mm. Additional fields and controls are show in Figure S2.the proximal region is able to further induce the expression of
both reporter genes (miR-223 and FLuc). On the contrary, the
DIST element is inactive in GMwhile, upon shift to differentiation,
is able to activate transcription. Notably, when the PROX and
DIST elements are present on the same construct, they act
synergistically providing the strongest activation (D-Fluc-P and
P-Fluc-D).
As indicated in Figure 1B, both regions contain E-box
elements and indeed both of them are able to bind MyoD in vivo,
as demonstrated by chromatin immunoprecipitation analysis
(Figure 2B). MyoD binding to DIST in GM conditions is in line360 Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc.with the notion that MyoD binds promoters prior to transcrip-
tional activation, which occurs upon its acetylation.
Nine regions spanning the entire locus (A-I, Figure 2C) were
tested for the major histone modifications in both GM and DM
conditions. Consistently with the promoter fusion analysis,
RNA polymerase II (RNAPII) enrichment is observed on the
PROX promoter already in GM. Interestingly, in these conditions,
no polymerase is found on miR-133b indicating that the PROX
promoter does not direct transcriptional read-through into this
region. These data are in agreement with the observation that
miR-133b expression is uncoupled from that of miR-206. Upon
Figure 2. Transcriptional and Epigenetic Regulation of miR-206/133b Genomic Locus
(A) Promoter activity assay. Upper panel shows that distal (box D) and proximal (box P) regions were cloned upstream of murine pre-miR-223 and tested in C2
myoblasts in GM and DM conditions. A region between miR-206 and miR-133b was used as negative control (dashed box). miR-223 expression was measured
by northern blot (Figure S3) and qRT-PCR. U6 snRNA was used as endogenous control. miR-223 relative quantification (RQ) is shown with respect to control
vector in GM set to a value of 1. Lower panel shows that the same regions were cloned, alone or in combinations, in a firefly luciferase reporter construct (FLuc)
and tested in GM and DM conditions. A luciferase construct (RLuc) was transfected as control. Luciferase activity, from three independent experiments, was
measured as FLuc/RLuc RQ shown with respect to the negative control vector in GM set to a value of 1.
(B) ChIP analysis for MyoD enrichment on distal (DIST), proximal (PROX) and negative control (CTRL) regions performed on chromatin extracted from C2
myoblasts in GM and DM conditions. Amplifications of IgG control immunoprecipitations (IgG) and 10% of input chromatin (Inp) are shown.
(C) Upper panel is a schematic representation of the miR-206/133b genomic locus. Capital letters indicate regions analyzed in ChIP experiments. Location of
regulatory regions (DIST, PROX and pA), pre-miRNAs (206, 133b) and linc-MD1 are shown along the locus as in Figure 1B. Lower panel displays ChIP analyses
for RNA polymerase II (RNAP II), H3K9ac, H3K27me3, andH3K4me3 performed on chromatin extracted frommyoblasts in GMandDM. Values derived from three
independent experiments were normalized for background signals (IgG) and expressed as percentage of Input chromatin (% Inp). Unless specifically indicated,
statistical significance was calculated with respect to GM conditions. Data are shown as mean ± SD. One asterisk indicates p < 0.05; two asterisks: p < 0.01.induction of differentiation, RNAPII immunoprecipitates on
the DIST promoter and on the entire region: RNAPII enrich-
ment decreases gradually along the cluster and increases
at the 30 end in a fashion similar to that of many transcrip-
tional units (Moore and Proudfoot, 2009). Histone-H3-lysine-9
acetylation (H3K9ac) and Histone-H3-lysine-27 tri-methylation
(H3K27me3) patterns are in agreement with the differential tran-
scriptional activity of the two promoters: low H3K27me3 and
high H3K9ac immunoprecipitation levels are found on the
PROX element already in GM and are maintained in DM (high-
lighted in gray). Conversely, DIST displays low H3K9ac and
high H3K27me3 signature in GM, while the pattern is reverted
upon differentiation, in line with transcriptional activation (high-
lighted in gray). Notably, the H3K4me3 marker, enriched around
TSS of active RNAPII promoters (Okitsu et al., 2010), confirmed
the presence of TSS on the distal region in DM conditions
(Figure 2C, lower panel). Interestingly, H3K4me3 was detected
also in region C where minor TSS were mapped (data notshown), suggesting the presence of additional transcripts in
this region.
Altogether, our data indicate that the PROX promoter is
responsible for miR-206 expression in growth conditions,
whereas upon differentiation, both PROX and DIST cooperate
to drive transcription of the locus.
Distal and Proximal Promoters Are Involved
in Long-Distance Interactions
Since promoter fusion assays demonstrated the cooperation
between the DIST and PROX elements, we investigated whether
these two regions could physically interact in vivo. Gene loops
have been shown to be transcriptionally dependent, as they
are absent in nontranscribing conditions (West and Fraser,
2005). Chromosome conformation capture (3C) analysis (Tan-
Wong et al., 2008) was utilized to determine relative crosslinking
frequencies among regions of interest. The conformation of the
miR-206/133b genomic locus was initially tested in myoblasts,Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc. 361
Figure 3. Tridimensional Architecture of miR-206/
133b Genomic Locus
(A) Upper panel shows StyI restriction sites (vertical lines),
regulatory regions (DIST, PROX, pA), pre-miRNAs (206,
133b), and linc-MD1. Capital letters (A–I, X, and Y) indicate
the position of StyI sites analyzed in 3C experiments. A–I
sites identify the same regions analyzed in ChIP experi-
ments in Figure 2C. A common reverse primer identifying
the proximal region (X) was used in combination with
different reverse primers. Lower panel shows 3C analysis
performed on chromatin extracted from C2 myoblasts in
GM and DM conditions and from fibroblast cell cultures.
Crosslinking frequencies relative to X region were
measured both by semiquantitative PCR (data not shown)
and qRT-PCR. Data from multiple experiments were
normalized for primer amplification efficiency and re-
ported with respect to X-B interaction in GM set to a value
of 1. Statistical significance was calculated with respect to
GM conditions.
(B) The same 3C analysis was performed in liver (LIV),
heart (HEA), tibialis anterior (TIB), soleus (SOL) of wild-type
(WT), and mdx animals. For each set of interactions
analyzed, crosslinking frequencies relative to X region
derived from multiple experiments were reported with
respect to WT HEA interaction set to a value of 1. Statis-
tical significance was calculated with respect to WT HEA
tissue. Data are shown as mean ± SD. One asterisk indi-
cates p < 0.05; two asterisks: p < 0.01.
(C) Schematic representation of the interactions detected
upon induction of differentiation.both in GM and DM conditions, as well as in fibroblasts where
the two miRNAs are not expressed. A common reverse primer
(indicated by X in Figure 3A) mapping in the PROX region was
used in combination with a set of primers along the genomic
locus and interactions were analyzed by qPCR (Figure 3A; note
that A-I sites correspond to the same regions analyzed in ChIP
experiments). A specific interaction between PROX and DIST
region (X-B) is observed upon induction of differentiation. A
less prominent but reproducible interaction is also detected
between X and the I, which identifies the polyadenylation region
(pA). No specific long-range interactions were detected in fibro-
blasts where the locus is silent.
An interaction, clearly distinguishable from the background, is
also found with the A region. This can be due to its proximity to
the DIST element, or it can point to the existence of an additional
enhancer region.
3C analysis was also performed in different types of mouse
tissues from WT and mdx animals. Figure 3B shows that the
interaction between the PROX and DIST regions only occurs in
skeletal muscles and it is characteristic of muscles with high
regeneration rate, such as the soleus (Charge´ and Rudnicki,
2004). Notably, PROX-DIST interaction is particularly enhanced
in mdx muscles, known to undergo intense regeneration (mdx
SOL). The same specificity was also detected for the PROX-pA
interaction (Figure 3B, X-I); on the contrary, no relevant interac-
tion was detected between PROX and a negative control
region (X-Y).
From these data, we conclude that the long-distance interac-
tion between the DIST and PROX is functional to both linc-MD1
and miRNAs expression. Figure 3C schematically shows the
looping structure correlated with the activation state of the locus.362 Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc.Modulation of linc-MD1 Expression Affects Myogenic
Differentiation
Figure 4A shows the expression profiles of myogenic proteins
(Myogenin - MYOG and Myosin Heavy Chain - MHC), linc-MD1
and muscle miRNAs (miR-206, miR-1 and miR-133) during
in vitro C2 myoblast differentiation. The analysis reveals that:
(1) miR-206 is already expressed in GM (in line with the observed
basal activity of the PROX promoter and its active chromatin
signature, Figures 2A–2C); (2) miR-1 and miR-133 expression
is delayed with respect to miR-206 (note that the probes used
do not distinguish between miR-133a and miR-133b); (3) linc-
MD1 expression starts from the third day of differentiation.
In order to understand the role of linc-MD1 in skeletal muscle
differentiation, we modulated its expression through RNA inter-
ference and overexpression experiments. The left panel in Fig-
ure 4B shows that, in C2 myoblasts, MYOG and MHC protein
levels decrease after 5 days of linc-MD1 interference (si-MD1)
with respect to control siRNA (si-scr). Two different constructs
were used for ectopic expression of linc-MD1 (see scheme in
Figure 4B): pMD1, carrying the conserved portion of linc-MD1
(Figure S1A), and pMD1-Ddrosha, containing a mutation in the
miR-133b flanking region that prevents Drosha cleavage and
miR-133b release. The use of both constructs should permit to
distinguish the effect of linc-MD1 from that of miR-133b that
can be produced in the nucleus from Drosha cleavage of the
linc-MD1 precursor. Figure S4 demonstrates that pMD1 is
indeed able to express high levels of miR-133b, while pMD1-
Ddrosha is not. Figure 4B (right panel) shows that both types
of constructs give rise to an increase of myogenic markers,
MYOG and MHC, with respect to control treatment (pCtrl). Inter-
estingly, pMD1-Ddrosha displayed a slightly stronger activity
Figure 4. Modulation of Linc-MD1 Expression Affects Myogenesis
(A) RNA and protein samples were extracted from myoblasts in proliferation
(GM) and after shift to differentiation medium (DM) for the indicated times.
Upper panels showwestern blot analysis for myogenin (MYOG), myosin heavy
chain (MHC), and HPRT. Middle panels show RT-PCR analysis for linc-MD1
and Actin mRNA (ACT) expression. Lower panels show northern blots for
miR-206, miR-1, miR-133, and snoRNA55.
(B) Left panel: siRNAs for linc-MD1 (si-MD1) or scramble control (si-scr)
transfected in C2 myoblasts and maintained in DM for 5 days. Right panel:
linc-MD1 overexpression was obtained by transfection of linc-MD1 (pMD1)
and linc-MD1-Ddrosha (pMD1-Ddrosha) constructs (see schematic repre-
sentation below) together with a control GFP cDNA (pCtrl). Samples were
collected 4 days after induction of differentiation. Densitometric analysis,
normalized for HPRT, is shown below. Lower panels display the levels of
linc-MD1, normalized for HPRT, measured by qRT-PCR.
Data are shownwith respect to control experiments set to a value of 1. Data are
shown as mean ± SD. One asterisk indicates: p < 0.05; two asterisks: p < 0.01.(more evident for MHC), indicating that the observed effects are
not due to miR-133b production but rather to linc-MD1 over-
dosage. Lower panels of Figure 4B indicate the relative quantifi-
cation of linc-MD1 with respect to controls. Considering the
disproportion between linc-MD1 abundance and the effects on
myogenic target synthesis, it is reasonable to postulate the exis-
tence of a threshold level above which the system cannot be
further influenced.
linc-MD1 Is a Target of miR-133 and miR-135
Bioinformatics analysis (see Extended Experimental Proce-
dures) for miRNA recognition sequences on linc-MD1 revealed
the presence of thirty-six highly conserved putative miRNA sites
listed in Table S1. We discarded miRNAs not expressed in
muscle as well as miRNAs whose targets are not expressed or
do not have a known function in muscle physiology. The two
remaining miRNA were miR-135, with two predicted sites on
linc-MD1 and miR-133, with one site (see Figure 5A and Table
S1; note that both members, a and b, of the miR-135 and
miR-133 families can associate with those sites on linc-MD1).
Interestingly the 70 nucleotide shorter isoform of linc-MD1 (see
Figure 1C) lacks the two miR-135 sites. In all subsequent exper-
iments we concentrated on the longest isoform containing the
miR-135 sites (linc-MD1 cDNA).The linc-MD1 cDNA (RLuc-MD1-WT) and mutant derivatives
lacking the putative miR-133 and miR-135 recognition se-
quences (RLuc-MD1-D133 and RLuc-MD1-D135) were cloned
downstream of the luciferase gene (Figure 5B) and transfected
in C2 myoblasts together with either miR-135 (pmiR-135a/b)
or miR-133 (pmiR-133a/b) coding plasmids. Figure 5B shows
that luciferase expression is reduced by 50% and 20% with
respect to the control plasmid (pCtrl) when miR-135 and mir-
133 were respectively expressed. These effects are abolished
when mutant substrates for either miRNA were utilized. qRT-
PCR for RLuc mRNA revealed that overexpression of both miR-
NAs do not affect luciferase mRNA stability (Figure S5A). These
data demonstrate that linc-MD1 can bind both miR-135 and
miR-133.
The different levels of repression exerted by the two miRNAs
could be due to the fact that linc-MD1 contains two miR-135
recognition elements and only one for miR-133. However,
it cannot be excluded that the presence of a pre-miR-133b
hairpin structure in the linc-MD1 sequence could limit miR-133
association.
linc-MD1 Controls miR-133 and miR-135 Targets
Among the many predicted targets of miR-135 and miR-133, we
concentrated on MEF2C (with one miR-135 site) and MAML1
(with two miR-133b sites) mRNAs since they encode for tran-
scription factors known to play a relevant role in myogenic differ-
entiation (Shen et al., 2006). Interestingly, comparative analysis
revealed that miRNA putative target sites in MEF2C and
MAML1 30UTR are highly conserved in mammals. The 30UTRs
of MAML1 and MEF2C were fused to the Luciferase coding
region (RLuc-maml1-WT and RLuc-mef2c-WT, Figure 5C) and
transfected in C2 myoblasts with plasmids encoding miR-133
(pmiR-133a/b) or miR-135 (pmiR-135a/b) in parallel to a control
plasmid (pCtrl). Luciferase assays show that MAML1 and
MEF2C are targets of miR-133 and miR-135, respectively (Fig-
ure 5C). The use ofmutant derivatives (-mut) in themiRNA recog-
nition sites confirms the specificity of the repressing activity.
Moreover, LNA against miR-133 ormiR-135were able to prevent
the repression by endogenous miRNAs on RLuc-maml1-WT and
RLuc-mef2c-WT, respectively (Figure S5B).
RLuc-maml1-WT and RLuc-mef2c-WT constructs were sub-
sequently transfected in C2 myoblasts together with pMD1-
DDrosha or mutant derivatives (pMD1-D135 and pMD1-D133;
see Figure 5D). Luciferase assays indicate that, in the presence
of the pMD1-DDrosha, both 30UTR reporter constructs are upre-
gulated (Figure 5D, black bars). This indicates that linc-MD1, by
binding miR-133 and miR-135, acts as a decoy abolishing
miRNA repressing activity on both MAML1 and Mef2C 30UTR.
On the contrary, when the pMD1-Ddrosha -D133 was used,
RLuc-maml1-WT repression is restored, as is also the case for
pMD1-DdroshaD135 on RLuc-mef2c-WT (dotted and dashed
bars, respectively). These effects were lost when both RLuc-
maml1-mut and RLuc-mef2C-mut were utilized.
Figure 6A shows MAML1 and MEF2C expression in parallel
with that of miR-133 and miR-135 during C2 myoblast differ-
entiation. The effect of linc-MD1 on MAML1 and MEF2C
endogenous proteins in combination with a modulation of
miRNA levels was monitored by different approaches shown inCell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc. 363
Figure 5. linc-MD1 Acts as a Natural Decoy for miR-135 and miR-133
(A) Positions of miR-135 and miR-133 binding sites on linc-MD1.
(B) linc-MD1 (RLuc-MD1-WT) and mutant derivatives devoid of miR-133 or miR-135 binding sites (RLuc-MD1-D133 and Rluc-MD1-D135) were cloned down-
stream the Renilla luciferase coding region (RLuc). These constructs were cotransfected in C2 myoblasts together with plasmids expressing miR-135 (pmiR-
135a/b) or miR-133 (pmiR-133a/b) or with a control vector (pCtrl).
(C) The 30UTR of MAML1 and of MEF2C were cloned downstream RLuc (RLuc-maml1-WT, RLuc-mef2c-WT) together with mutant derivatives lacking miRNA
recognition sequences (RLuc-maml1-mut and RLuc-mef2c-mut). These constructs were cotransfected in C2 myoblasts with plasmids expressing miR-133
(pmiR-133a/b) ormiR-135 (pmiR-135a/b) or with a control vector (pCtrl). (D) RLuc-maml1-WT, RLuc-mef2c-WT and their correspondingmutant derivatives (-mut)
were transfected in C2 myoblasts with pMD1-Ddrosha or its mutant derivatives depleted in either miR-135 (pMD1-Ddrosha-D135) or miR-133 (pMD1-Ddrosha-
D133) recognition elements. A GFP construct was used as control (pCtrl). FormiRNA overexpression experiments, unless specifically stated, amix of a and b pre-
miRNA expression plasmids was used. For all the experiments, histograms indicate the values of luciferase measured 24 hr after transfection. Data, derived
from three independent experiments, are shownwith respect to RLuc control vector set to a value of 100%. Data are shown asmean ± SD. One asterisk indicates
p < 0.05.Figure 6B: (1) LNA against miR-133 and miR-135; (2) RNAi
against linc-MD1; (3) RNAi against linc-MD1 in combination
with LNA against miR-133 and miR-135; and (4) overexpression
of linc-MD1 either in its wild-type form or in its Ddrosha mutant
derivative. The results indicate that the levels of MAML1 and
MEF2C increase in the presence of LNA against miR-133 and
miR-135, while they decrease in the absence of linc-MD1.
Notably, LNA are able to resume synthesis of both proteins
when linc-MD1 was downregulated by RNAi. Finally, the overex-
pression of linc-MD1 either in its wild-type form or in its Ddrosha
mutant derivative produced an increase of MAML1 and MEF2C
expression. These data indicate the existence of a specific
crosstalk between the linc-MD1 RNA and MAML1 and MEF2C
mRNAs through competition for miR-133 and miR-135 binding.
If linc-MD1 effectively acts as a decoy, one would expect
that the relative concentration of the decoy and the miRNAs
affects the expression of the target mRNAs. We gradually
increased the amount of miRNAs in the presence of increasing
amount of linc-MD1-Ddrosha. Figure 6C indicates that the levels
of the endogenous MAML1 and MEF2C are higher in excess of
linc-MD1 and are gradually reduced when miRNA levels are
increased. This further proves that there is an interplay among
the three components.
Since muscle creatine kinase (MCK, which increases during
muscle differentiation as shown in Figure 6A) was previously
shown to be controlled by MEF2C in concert with MAML1
(Shen et al., 2006), we tested the effect of linc-MD1 knockdown
and overexpression on this downstream target. Figure 6D shows364 Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc.that the amount of MCK directly correlates with that of its
transcriptional activators, demonstrating that the linc-MD1
and miR-133/135 circuitry indeed impinges on muscle gene
expression.
Altogether these data indicate that linc-MD1, by binding
miR-133 and miR-135, acts as a competing endogenous RNA
(ceRNA) for their mRNA targets, including MAML1 and MEF2C,
which encode crucial myogenic factors required for the activa-
tion of muscle-specific genes. In line with a decoy mechanism,
the predicted DG of binding (Enright et al., 2003) of the miRNAs
with linc-MD1 is lower than that with the respective targets
(Figure S6).
The linc-MD1 Function Is Conserved in Human
Myoblasts
Taking advantage of the presence of conserved regions in linc-
MD1, we amplified a linc-MD1 human homolog from differenti-
ated primarymyoblasts. We confirmed the exon/intron organiza-
tion and, in particular, the conservation around the recognition
motifs for miR-135 and miR-133. Human primary myoblasts
were analyzed in parallel with Duchenne myoblasts (DMD),
characterized by mutations in the dystrophin gene and known
to have a reduced ability of undergoing terminal differentiation
(Cacchiarelli et al., 2011). Figure 7A shows that, compared to
control cells, DMD myoblasts display a reduced and delayed
accumulation of the muscle-specific markers MYOG and MHC.
Notably, in DMD cells the linc-MD1 levels are strongly reduced.
This, together with the unaffected accumulation of miR-135,
Figure 6. linc-MD1 Modulates MAML1 and MEF2C Expression in Muscle
(A) Western blot analysis for MAML1, MEF2C, and MCK, in growth medium (GM) and at different days upon shift to differentiation conditions (DM). The relative
expression of miR-133 and miR-135 is also reported.
(B) MAML1 andMEF2C levels upon modulation of miRNA and linc-MD1 levels in C2 myoblasts maintained in DM for 5 days. Modulation was obtained with: anti-
miR-133 and anti-miR-135 LNAs, RNAi against linc-MD1, and linc-MD1 overexpression (pMD1 and pMD1-Ddrosha). Scrambled LNA (LNA-scr) and siRNA
(si-scr) were used as control. HPRTwas used as a loading control. Below each panel, relative quantifications with respect to control samples set to a value of 1 are
displayed.
(C) Western blot for the same proteins from C2 myoblasts transfected with different combinations of pMD1-Ddrosha and pmiR-133/pmiR-135 expression
plasmids. (+) corresponds to 1.5 mg pMD1-Ddrosha and to 50 ng of pmiR-133/miR-135, while (++) corresponds to 300 ng of pmiR-133/pmiR-135. Control
myoblasts were transfected with a GFP plasmid (). The values, derived from densitometric analysis, are reported with respect to mock samples set to a value of
1. Data are shown as mean ± SD. One asterisk indicates p < 0.05.
(D) MCK measured in cells treated with the indicated LNA or siRNAs as in panel (B).likely determines low levels of MEF2C; vice versa, the strong
downregulation of miR-133 correlates with the upregulation of
MAML1. The same results were also obtained during differentia-
tion of satellite cells derived from wild-type and mdx mice
(Figure S7).
Interestingly, when DMD myoblasts were infected with a
lentiviral construct expressing the murine pMD1-Ddrosha, the
expression levels of MYOG and MHC as well as those of
MEF2C are restored toward control levels (Figure 7B). Despite
the upregulation of miR-133, which parallels linc-MD1 overex-
pression, MAML1 levels increase indicating that the amount of
linc-MD1 is sufficient to overcome miR-133 repression activity.
In conclusion, these data indicated that linc-MD1 RNA is
expressed also in human muscle cells where it modulates miR-
133 and miR-135 targets, playing an important role in the timing
control of myoblast differentiation.
DISCUSSION
It is becoming largely accepted that the noncoding portion of the
genome rather than its coding counterpart is likely to account for
the greater complexity of higher eukaryotes. Many new functions
have been assigned to noncoding RNAs both in the nucleus and
in the cytoplasm (Mattick, 2011; Nagano and Fraser, 2011).
Likewise, similar to what happened for the well-known small
noncoding RNAs, long noncoding RNAs are now attractingmuch interest. Recent data suggest that coding and noncoding
RNAs can regulate one another through their ability to compete
for miRNA binding; these molecules have been termed com-
peting endogenous RNA (ceRNA, Salmena et al., 2011). ceRNAs
can sequester miRNAs, thereby protecting their target RNAs
from repression (Karreth et al., 2011 [this issue of Cell]; Sumazin
et al., 2011 [this issue ofCell]; Tay et al., 2011 [this issue of Cell]).
In this paper, we identify a muscle-specific long noncoding
RNA (linc-MD1) that displays decoy activity for two specific
miRNAs and, in doing so, regulates their targets in a molecular
circuitry affecting the differentiation program.
Weshowthat linc-MD1 is encodedbyagenomic locuscontain-
ing the miR-206 and miR-133b coding regions and demonstrate
that there is a complex architecture in terms of transcriptional
control in this locus: while miR-206 is expressed autonomously
from its own proximal promoter, miR-133b is cotranscribed
with linc-MD1 RNA which derives from a 13 Kb distal promoter.
Here, we provide evidence of the existence of two distinct
promoters: (1) miR-206 is already expressed in growing
myoblasts, whereas miR-133b and linc-MD1 are activated only
upon differentiation; (2) 50 RACE and promoter fusion experi-
ments indicate the existence of two transcriptional regulatory
elements (DIST and PROX); (3) ChIP experiments for RNA Poly-
merase II and different markers of chromatin activity indicate
a well-defined chromatin organization of the two transcriptional
units. In particular, in growth conditions, only the PROXpromoterCell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc. 365
Figure 7. linc-MD1 Is Conserved in Humans, and It Improves Differentiation of Duchenne Myoblasts
(A) Myoblasts derived from healthy (Control) and Duchenne Muscular Dystrophy (DMD) individuals were induced to differentiate for the indicated times and RNA
and protein samples were collected. Western blot analysis for the indicated proteins was performed in parallel with qRT-PCR for the expression of linc-MD1,
miR-133 and miR-135.
(B) DMD myoblasts were infected with lentiviral vectors carrying a control GFP-expressing cassette (lenti-Ctrl) or the linc-MD1-Ddrosha construct under the
control of the CMV promoter (lenti-MD1). Cells were induced to differentiate for the indicated times and RNA and protein samples were collected. Western blot
analysis for the indicated proteins was performed in parallel with qRT-PCR for the expression of linc-MD1, miR-133 and miR-135. Data are shown as mean ± SD.
One asterisk indicates p < 0.05.
(C) Schematic representation of the circuitry linking linc-MD1, miR-135, miR-133, and muscle differentiation.displayed markers of transcriptional activation, and no RNAPII
loading was detected on the miR-133b region. These data
suggest that miR-133bmainly originates from the DIST promoter
by processing of linc-MD1.
linc-MD1 accumulates as a cytoplasmic poly-A+ RNA, sup-
porting the conclusion that this species is the remaining portion
of the transcript that escaped Drosha cleavage inside the
nucleus. We prove that indeed miR-133b is produced with
ectopic expression of linc-MD1. In order to avoid a possible
confusion between the effect of linc-MD1 and that of miR-133b
release, a mutant linc-MD1 derivative lacking the ability to
release miR-133b was utilized in most of the overexpression
experiments. Future work will address themechanism regulating
the relative ratio betweenmiR-133b processing and the export of
the unprocessed precursor.
Notably, we show that transcriptional activation of the linc-
MD1 promoter correlates with the formation of a DNA loop in
which the distal and proximal promoters (and the polyadenyla-
tion region) are connected in a functional/structural interaction.
So far, gene loops have been shown to be transcription-depen-
dent, because they are absent in nontranscribing conditions
and have been suggested to represent specific structural
domains of active chromatin (Tan-Wong et al., 2008; West and
Fraser, 2005). Therefore, a drastic structural change occurs in
the miR-206/miR-133b locus; in growth conditions, only the
proximal promoter is active and no long-distance interactions366 Cell 147, 358–369, October 14, 2011 ª2011 Elsevier Inc.occur, while upon differentiation, a DNA loop is observed
between distantly located regions, and this correlates with acti-
vation of the distal promoter and consolidation of the overall
transcription of the locus.
As far as the function of linc-MD1 is concerned, we show that
its modulation impinged on myogenesis. linc-MD1 RNAi-depen-
dent downregulation in mouse myoblasts produced a decrease
in the accumulation of myogenic markers, while its overexpres-
sion led to increased synthesis. linc-MD1 was found to be con-
served in human cells: high levels were observed upon induction
of differentiation in wild-type cells, whereas strongly reduced
levels were found in Duchenne myoblasts. This observation is
in line with the well-known delay observed in the differentiation
program of DMD myoblasts (Cacchiarelli et al., 2011). Notably,
when linc-MD1 expression was restored to wild-type levels in
DMDmyoblasts, the timing and expression level of themyogenic
factors were partially rescued toward wild-type levels.
According to the ceRNA hypothesis, lncRNAs may elicit their
biological activity through their ability to act as endogenous
decoys for miRNAs; such activity would in turn affect the distri-
bution of miRNAs on their targets (Salmena et al., 2011). We
searched for miRNA recognition motifs in the linc-MD1
sequence and found that the presence of recognition sites for
miR-133 and miR-135 could be reliably predicted. linc-MD1
was validated as target for both these miRNAs since they
induced translational repression of a reporter gene.
Among the many different putative targets for these miRNAs,
we discovered two mRNAs encoding for proteins with a relevant
function in myogenesis: the Myocyte-specific enhancer factor
2C (MEF2C), targeted by miR-135 and Mastermind-like-1
(MAML1) controlled by miR-133.
Consistent with linc-MD1 being a decoy for miR-133 and miR-
135, we proved that its depletion reduced the levels of both
MAML1 and MEF2C while its overexpression produced an
increase in protein accumulation. These data are consistent
with the idea that decoy lincRNAs are transmodulators of gene
expression through miRNA binding.
The identification of the targets indirectly controlled by linc-
MD1 can be instrumental to explain the myogenic alterations
observed upon its deregulation. MEF2C belongs to a family of
transcription factors that bind the control regions of numerous
muscle-specific genes activating their expression (Lin et al.,
1997). Moreover, it was shown to play a key role in differentiation
ofmuscle cells (Lilly et al., 1995) and in themaintenance of sarco-
mere integrity (Potthoff et al., 2007).
On the other side, the Mastermind-like genes encode critical
transcriptional coactivators for Notch signaling. Additionally,
the MAML proteins were described as transcriptional coactiva-
tors in other signal transduction pathways including muscle
differentiation: mice with a targeted disruption of the MAML1
gene had severe muscular dystrophy and MAML1-null embry-
onic fibroblasts failed to undergo MyoD-induced myogenic
differentiation (Shen et al., 2006). Moreover, ectopic MAML1
expression in mousemyoblasts dramatically enhancedmyotube
formation and increased the expression of muscle-specific
genes, while MAML1 knockdown inhibited differentiation.
Even more interesting is the finding that MAML1 and MEF2C
specifically interact and act synergistically to activate several
genes required for muscle development and function, including
muscle creatine kinase (MCK). TheMAML1 promyogenic effects
were completely blocked upon activation of Notch signaling,
which was associated with recruitment of MAML1 away from
MEF2C to the Notch transcriptional complex (Wilson-Rawls
et al., 1999). Therefore, a crosstalk between MAML1 and Notch
was postulated to influence myogenic differentiation.
In light of these notions, we proved that depletion of linc-MD1
led to repression of both MAML1 and MEF2C, while its overex-
pression restored their synthesis at high levels. Notably, in condi-
tions of linc-MD1 excess, titrated repression of bothMAML1 and
MEF2C could be obtained by increasing miR-133 and miR-135
levels. This indicated a direct competition for miRNA binding
between linc-MD1 and mRNAs, allowing us to conclude that
the three components crosstalk with one another at the post-
trascriptional level. Notably, MCK, a known target of MEF2C,
coherently behaved as part of the circuitry: it increased upon
linc-MD1 overexpression and decreased upon linc-MD1 RNAi.
In Duchenne muscle cells the rescue of linc-MD1 through
lentiviral-mediated expression produced the recovery of both
MAML1 and MEF2C synthesis and partial rescue of the correct
timing of the differentiation program. These data allowed us to
conclude, that also long noncoding RNAs play a relevant role
in the complex network of regulatory interactions governing
muscle terminal differentiation. Moreover, the discovery of
the decoy role of lncRNA opens the road to the prediction andidentification of new regulatory networks acting through miRNA
competition.
EXPERIMENTAL PROCEDURES
Cell Cultures and Treatments
C2 myoblasts (C2.7 clone) were transfected with plasmid DNA using lipofect-
amine-2000. (Invitrogen). siRNA molecules designed against linc-MD1 exon2
and exon3 sequences (see supplementary experimental procedures) where
transfected using HiPerfect (QIAGEN). LNA oligos against miR-133a/b and
miR-135a/b (EXIQON) were transfected using XtremeGene (Roche). All trans-
fections were performed according to manufacturer’s specifications.
Control and Duchenne primary myoblasts carrying exon 44 deletion
(obtained from Telethon Biobank), were grown and infected with lenti-Ctrl
and lenti-MD1 constructs according to Incitti et al. (2010). Muscle satellite cells
were cultured and differentiated as described in Cacchiarelli et al. (2010).
Chromatin Immunoprecipitation Assays
ChIP analyses were performed on chromatin extracts from myoblasts (GM)
and myotubes (DM) according to manufacturer’s specifications (MAGnify
ChIP - Invitrogen) with the following antibodies: RNA Polymerase II, MyoD
(Santa Cruz), anti-acetyl-HistoneH3 (Lys9), anti-acetyl-HistoneH3 (Lys4), and
anti-trimethyl Histone H3 (Lys27) (Millipore).
A standard curve was generated for each primer pair testing 5-point
dilutions of input sample. Fold enrichment was quantified using qRT-PCR
(QuantiTect SYBR Green - QIAGEN) and calculated as a percentage of Input
chromatin (% Inp). Data were normalized to an unrelated genomic region
and are representative of three independent experiments. Primer sequences
are available upon request.
3C Analysis
The 3C assay was performed as described by Tan-Wong et al., 2008. Briefly,
chromatin was crosslinked with 1% formaldehyde and nuclei were isolated by
using Nonidet P-40. DNA was digested with 800 units of StyI restriction
enzyme and ligated in 1X ligation buffer (NEB). Ligation products were purified
using QIAquick PCR purification kit (QIAGEN). Two types of controls were
included in the analysis. First, to ensure that primer efficiency does not intro-
duce bias, a control template was generated by digesting and ligating
equimolar amounts of all possible PCR products and used to calculate ampli-
fication efficiency of each primer pairs. Second, a loading control was gener-
ated by amplifying part of HPRT promoter to evaluate total amount of DNA
used in the 3C analysis. We confirmed that all 3C primers amplified an artificial
control template but not undigested and ligated, or digested but not ligated
chromatin. Therefore we verified that the sequence of all 3C products was
correct (data not shown).
3C products detection was done in triplicate by GoTaq qPCR (Promega)
according to manufacturer’s instructions. Data were analyzed according
Abou El Hassan and Bremner, (2009). Primer sequences are available upon
request.
Statistical Analyses
The data shown in the histograms are the result of at least three independent
experiments performed on at least three samples or animals. Unless stated
otherwise, data are shown as mean ± standard deviation (SD) and statistical
significance of differences between means was assessed by two-tailed
t test and p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, one
table, and seven figures and can be found with this article online at doi:10.
1016/j.cell.2011.09.028.
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